Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body. In 2022 alone, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. Despite those numbers, outcomes have improved dramatically: the five-year survival rate for all cancers combined has risen from 49% in the mid-1970s to 69% today.
How Normal Cell Growth Goes Wrong
Your body is constantly making new cells. Old or damaged cells die on schedule, and fresh ones replace them. Cancer starts when that orderly cycle breaks down. Damaged cells that should die instead keep dividing, producing more abnormal cells that the body doesn’t need.
This breakdown is driven by changes in genes, specifically genes that control how cells grow, divide, and die. These genetic changes can be inherited, but most accumulate over a lifetime through exposure to things like tobacco smoke, ultraviolet radiation, or certain viruses. Sometimes they happen randomly when cells copy their DNA during division.
Three types of genes are most often involved. Growth-promoting genes (called proto-oncogenes) act like a gas pedal for cell division. When one of these mutates, it can get stuck in the “on” position, pushing the cell to keep multiplying. Tumor suppressor genes work like brakes, slowing division or telling damaged cells to self-destruct. When these genes stop working, there’s nothing to stop runaway growth. DNA repair genes normally fix mistakes in a cell’s genetic code. When they fail, other mutations pile up faster.
What Makes Cancer Cells Different
Cancer cells don’t just grow faster. They behave in fundamentally different ways than healthy cells. They grow without the signals that normal cells need to start dividing. They ignore signals telling them to stop. They dodge programmed cell death, the built-in self-destruct process that normally eliminates damaged cells. They even recruit blood vessels to grow toward the tumor, securing their own nutrient supply.
Perhaps most dangerously, cancer cells hide from the immune system or trick it into helping them survive. Your immune system is designed to detect and destroy abnormal cells, but cancer cells can alter their surface markers to avoid detection or release chemical signals that suppress immune attacks.
How Cancer Spreads
A tumor that stays in one place is concerning, but what makes cancer life-threatening is its ability to spread, a process called metastasis. Cancer cells at the edge of a tumor can detach from their neighbors, break through the surrounding tissue barrier, and enter the bloodstream or lymphatic system. Once in circulation, they travel to distant organs, exit the blood vessels, and establish new tumors.
Not every cancer cell that enters the bloodstream succeeds. Most die along the way. But the ones that survive and colonize a new site create secondary tumors that are often harder to treat than the original. A breast cancer that spreads to the lungs, for example, is still breast cancer, and it’s treated as such, but the fact that it has spread changes the prognosis significantly.
Benign vs. Malignant Tumors
Not every tumor is cancer. Benign tumors can grow but don’t invade nearby tissues or spread to other parts of the body. They can sometimes cause problems by pressing on organs or nerves, but they’re generally not life-threatening. Malignant tumors are cancerous. They invade surrounding tissue, can metastasize, and tend to grow faster with a richer blood supply. When doctors remove a suspicious lump and send it for testing, the key question is whether it’s benign or malignant.
The Four Major Categories
Cancer isn’t one disease. It’s a collection of more than 100 diseases, classified by the type of tissue where they start.
- Carcinomas begin in the cells lining your organs and skin. They account for 80 to 90 percent of all cancer cases and include breast, lung, colon, and prostate cancers.
- Sarcomas start in connective and supportive tissues like bone, muscle, cartilage, and fat.
- Leukemias are cancers of the bone marrow, where blood cells are produced. They’re sometimes called liquid cancers because they don’t form solid tumors.
- Lymphomas develop in the lymphatic system, the network of vessels, nodes, and organs that produces infection-fighting white blood cells.
How Cancer Is Staged and Graded
When cancer is diagnosed, doctors assess two things: how far it has spread (the stage) and how abnormal the cells look under a microscope (the grade). Both shape treatment decisions and outlook.
Staging typically uses the TNM system. T describes the size of the primary tumor, with higher numbers meaning a larger or more invasive tumor. N indicates whether cancer has reached nearby lymph nodes, and if so, how many. M tells whether cancer has metastasized to distant parts of the body. A cancer labeled T2N1M0, for instance, is a moderately sized tumor that has reached one or more nearby lymph nodes but hasn’t spread to distant organs.
Grading runs from 1 to 4 and reflects how much cancer cells resemble normal tissue. Grade 1 cells look close to normal and tend to grow slowly. Grade 4 cells look highly abnormal and typically grow and spread more aggressively. A low-grade cancer caught at an early stage generally has a much better prognosis than a high-grade cancer diagnosed after it has spread.
Survival Rates Vary Widely by Type
The word “cancer” covers an enormous range of outcomes. Thyroid cancer has a 98% five-year survival rate. Prostate cancer sits at 97%, and melanoma at 94%. On the other end, pancreatic cancer has a 13% five-year survival rate, and lung cancer sits at 27%.
Some cancers have seen remarkable improvement. Liver cancer survival has jumped from 3% to 22%, a seven-fold increase in relative terms. Female breast cancer survival is now 91%. Even leukemia, once considered almost uniformly fatal, has a 67% five-year survival rate. These gains reflect better screening, earlier detection, and treatments that are increasingly tailored to the specific genetic changes driving each person’s cancer.
Where a cancer is diagnosed on its journey, from a small localized tumor to widespread metastatic disease, remains one of the strongest predictors of outcome. This is why screening tests for common cancers like breast, colon, cervical, and lung cancer carry real value. Catching abnormal cells before they’ve had the chance to spread changes the math considerably.